A look at peptide therapy pitched for healing and longevity, and how the recent US policy change could ripple into India.
Recap by typeshit. Full story at The Indian Express.
The chain says it is exploring concepts including grilled items aimed at GLP-1 users, a sign of how the drugs are shifting food businesses.
Ahead of results, Kalkine looks at how costly late-stage trials for Amgen's monthly obesity shot MariTide weigh on the outlook.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
A beauty take that waves off pricey LA peptide and salmon sperm serums, saying better anti-aging habits are found closer to home.
A short take arguing that metabolic drugs are valid tools and that people who use them shouldn't feel they have to keep it quiet.
The JAMA Network Open study scanned about 150,000 posts, and increased appetite was the top complaint. The authors say it can't prove the drug caused it.
Loading…